View Dr. Abel's PubMed for 2008
View all of Dr. Abel's publications on PubMed

  1. Bray MS, Shaw CA, Moore MW, Garcia RA, Zanquetta MM, Durgan DJ, Jeong WJ, Tsai JY, Bugger H, Zhang D, Rohrwasser A, Rennison JH, Dyck JR, Litwin SE, Hardin PE, Chow CW, Chandler MP, Abel ED, Young ME. Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism and gene expression. 2008: Am J Physiol Heart Circ Physiol. 294(2): H1036-47. PMC: 2519224
  2. Yin Z, Jones G, Towns WH, Zhang X, Abel ED, Binkley PF, Jarjoura D, Kirschner LS. Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. 2008: Circulation. 117:1414-22. PMID: 18316483
  3. Amiott EA, Lott P, Soto J, Kang PB, M.D McCaffery JM, DiMauro S, Abel ED, Flanigan KM, Lawson VH, Shaw JM. Mitochondrial Fusion and Function in Charcot-Marie-Tooth Type 2AFibroblasts with Mitofusin 2 Mutations. Experimental Neurology, 2008. 211:115-27. PMC: 2409111
  4. Jouihan HA, Cobine PA, Hoagland EA, Boudina S, Abel ED, Winge DR, McClain DA. Insulin deficiency associated with decreased mitochondrial function and abnormal metal distribution in a mouse model of hemochromatosis is reversed by manganese supplementation. Molecular Medicine. 2008 14:98-108.
  5. Tabbi-Anneni I, Buchanan J, Cooksey RC, Abel ED, Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts. 2008: Endocrinology. 149:4043-4050. PMC: 2488224
  6. Fang C, Gu J, Xie F, Behr M, Yang W, Abel ED, Ding X. Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated cardiac toxicity. 2008: Drug Metab Dispos. 36:1722-1728. PMID: 18463197
  7. Lehman JJ, Boudina S, Banke NH, Sambandam N Phd, Han X, Young DM, Leone TC, Gross RW, Lewandowski ED, Abel ED, Kelly DP. The Transcriptional Coactivator PGC-1{alpha} is Essential for Maximal and Efficient Cardiac Mitochondrial Fatty Acid Oxidation and Lipid Homeostasis. 2008: Am J Physiol Heart Circ Physiol. 295:H185-196. PMC: 2494758
  8. Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J, Tuinei J, Homma S, Jiang XC, Abel ED, Goldberg IJ. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. 2008: J Lipid Res. 49:2101-2112. PMC: 2533410
  9. Augustus AS, Buchanan J, Addya S, Rengo G, Pestell R, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP. Substrate uptake and metabolism are preserved in hypertrophic Caveolin-3 Knockout Hearts. Am J Physiol Heart Circ Physiol. 2008: 295:H657-666. PMC: 2519224
  10. Mossalam M, Jeong J-H, Abel ED, Kim SW, Kim Y-H. Reversal of oxidative stress in endothelial cells by controlled release of adiponectin. Journal of Controlled Release. 2008: 130: 234-237. PMID: 18619503
  11. Bugger H, Boudina S, Hu XX, Tuinei J, Zaha VG, Theobald HA, Yun UJ, McQueen AP, Wayment B, Litwin SE, Abel ED, Type 1 diabetic Akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes. 2008 57:2924-2932. PMC: 2570388
  12. Augustus AS, Buchanan J, Gutman E, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP. Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism. Cell Cycle. 2008 7:2509-2518. PMID: 18719368
  13. Kim J, Wende AR, Sena S, Theobald HA, Soto J, Sloan C, Wayment BE, Litwin SE, Holzenberger M, LeRoith D, Abel ED, IGF-1 Receptor signaling is required for exercise-induced cardiac hypertrophy. Molecular Endocrinology. 2008: 22:2531-2543. PMC: 2582541